Choose your role and continue a guided genomic review workflow.
This workspace is organized around the jobs users need to complete. Start a case, run a safe report check, create a review-ready package, invite reviewers, complete sign-off, or manage billing. Technical audit details stay in Advanced sections only.
All demo workflows use synthetic or de-identified content. Tynixa prepares review-ready drafts and explanations only; final clinical decisions require qualified human review.
Role workspace paths
Choose a role to see the cases, review, evidence, billing, and support paths that apply to that user.
Default Genomics Lab path
If role switching is unavailable, this workspace still opens the complete lab demo: start a synthetic/de-identified case, create a review-ready package, and route it to human review.
Each role opens a working path with clear content, a safe demo boundary, and a next step. Research and admin paths are intentionally framed as de-identified research or operations workflows, not patient-level final clinical output.
Doctor / Patient
Safe explanation and questions for a clinician. No diagnosis, treatment, or final ACMG classification.
Researcher
De-identified evidence signals, uncertainty, and research demo activation without patient-level finalization.
Admin / Operator
Billing, workspace setup, team, and support paths. Billing never unlocks autonomous clinical release.
P248 Genomic Review Operating System
Scientific Review Room is now integrated into the workspace.
This panel unifies the Public Review Room, Internal Scientific Review Room, Evidence Operating System, Review Intelligence, and Closure Status inside the main workspace. It uses only synthetic/de-identified context by default and allows governed public NCBI checks without PHI.
Real-data mode is limited to public NCBI data only. No patient names, no PHI, no raw identifiers, no final diagnosis, no final ACMG, no treatment recommendation, and no clinical release.
Waiting for workspace check...
Workspace actions
Researcher workspace paths
Researcher intelligence routes
Visible sections are limited to researcher/lab roles and lead only to working pages with a next step. All routes remain synthetic/de-identified, draft-only, and human-review-first.
P248-RW linked
Evidence Intelligence
Inspect evidence gaps, counter-evidence, freshness, and graph signals in a de-identified workflow.
Advanced capabilities are role-gated. Doctor and patient roles receive safe explanation and review activation, while research and governance tools appear only for the appropriate roles.
Evidence Intelligence
Evidence gaps, counter-evidence, freshness, and explainability signals for review-ready packages.
The demo can explain, summarize, and prepare questions. It provides no final diagnosis, no final ACMG classification, and no treatment decisions.
Safe report demo
Doctor and patient roles open a complete guided report explanation.
Review package
The package view shows memo, evidence, gaps, conflicts, review route, and finalization block.
Human review
Reviewer mode and sign-off queue are connected to the governed review workflow.
Support
Pilot/support requests remain synthetic/de-identified until contract and security review.
Role-aware access boundaries
Public
Visitors see product, demo, pricing, resources, and pilot-request pages only.
App workflows
Signed-in or demo users see case intake, review packages, reviewer workflow, billing, and support paths.
Advanced capabilities
Evidence, research, governance, and explainability tools appear only for roles that can safely use them.
Safety: patient and doctor paths stay focused on safe explanation, questions, and professional review. Research and governance tools are not exposed as patient-level final clinical outputs.
Workspace overview
What this page does
Use this workspace to choose the right governed genomic review workflow for your role.
Who should use it
Genomics labs, lab directors, doctors, researchers, and operators starting a guided demo or review workflow.
What you get
A role-aware path to cases, review packages, evidence checks, review board actions, billing, and support.
What is not allowed
The workspace does not issue final diagnosis, final ACMG classification, treatment advice, or autonomous clinical release.
Example in practice
A lab user starts a synthetic VCF case, creates a review-ready package, and routes it to a reviewer.
Next step
Select your role, start a synthetic case, or open the unified demo path that matches your workflow.
Workspace value moments
The workspace shows the commercial value created by each role path before users move to review, pilot, billing, or support.
Case Readiness
Users see whether a synthetic case is ready before creating a review package.
Basis: readiness-score and PHI precheck workflow
Finalization Protection
Unsafe clinical release remains blocked until qualified sign-off.
Basis: finalization firewall and review package safety flags
Activation Path
Each role has a next step: run a demo, start a case, open review, request pilot, or get support.
Safety: These value moments are event-based and review-context-only. They do not claim autonomous diagnosis, final ACMG classification, treatment decisions, clinical performance approval, regulatory approval, unsupervised clinical automation, same-visit final clinical decisions, or clinical release without qualified human sign-off.
Registry-enforced surface boundaries
Tynixa separates public pages, app workflows, advanced capabilities, and guarded routes so users see only the surfaces that match their role and workflow.
Public: demo, pricing, resources, and pilot request pages.
App workflows: case intake, review packages, reviewer mode, sign-off, billing, and support.
Advanced capabilities: evidence, research, governance, and explainability surfaces are role-gated.
Guarded routes: older or non-guided pages are noindex and route users back to supported workflows.
Next step: choose a role above or start with the guided demo.